|
Volumn 19, Issue 4, 2000, Pages 259-264
|
Interferon alfa-2a (Roferon-A) in the management of chronic hepatitis B infection: results of an open prospective study in Nigerian patients.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA2A INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
ADULT;
ARTICLE;
BIOPSY;
BLOOD;
DRUG MONITORING;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNOLOGY;
LEUKOCYTE COUNT;
MALE;
METABOLISM;
MIDDLE AGED;
NIGERIA;
PATHOLOGY;
PROSPECTIVE STUDY;
SAFETY;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
ADULT;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
BIOPSY;
DRUG MONITORING;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
LEUKOCYTE COUNT;
MALE;
MIDDLE AGED;
NIGERIA;
PLATELET COUNT;
PROSPECTIVE STUDIES;
SAFETY;
TREATMENT OUTCOME;
|
EID: 0034303663
PISSN: 0189160X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|